Skip to main content
Retour
Watch Compare

Odyssey Health, Inc.

Qualité des données : 83%
ODYY
OTC Manufacturing Measuring & Analyzing Instruments
0,08 €
▲ 0,01 € (16,92%)
Cap. Boursière: 6,49 M
6 months return
—
Momentum
Neutral
Free cash flow
-620 457,0

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -620 457,0

Price History

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,06
Interest Coverage-1,23

Valorisation

PE (TTM)
-1,41
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -1,4 -1,5
P/B — 1,6
ROE % — -54,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E — 0,3

Objectif de Cours des Analystes

Consensus des analystes : objectif moyen vs prix actuel et notation.

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Prévisions d’EPS et de chiffre d’affaires par période. Annuel = exercices ; trimestriel = prochains trimestres.

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -4,59 M
ROE N/A ROA -1061,07%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -620 457,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,06
Interest Coverage -1,23 Asset Turnover N/A
Working Capital -10,60 M Tangible Book Value -10,60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,41 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9,56%
Market Cap 6,49 M Enterprise Value 6,49 M
Per Share
EPS (Diluted TTM) -0,05 Revenue / Share N/A
FCF / Share -0,01 OCF / Share -0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 13,52%
SBC-Adj. FCF -692 725 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0,0
Net Income -1,74 M -842 316,0 -5,92 M -8,44 M -16,88 M
EPS (Diluted) -0,02 -0,01 -0,07 -0,09 —
Gross Profit — — — — 0,0
Operating Income -1,02 M 14,26 M -5,31 M -8,11 M -15,86 M
EBITDA — — — — —
R&D Expenses 0,0 — — — 1,63 M
SG&A Expenses — — — — —
D&A — 1 538,0 3 416,0 2 374,0 5 552,0
Interest Expense 252 516,0 518 476,0 614 083,0 836 294,0 1,07 M
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 49 723,0 586 146,0 455 793,0 569 677,0 610 533,0
Total Liabilities — — — — 3,38 M
Shareholders' Equity -6,95 M -5,33 M -6,16 M -4,64 M -2,77 M
Total Debt — — — — 0,0
Cash & Equivalents — — 36 865,0 72 534,0 556 584,0
Current Assets 49 723,0 56 943,0 405 888,0 526 417,0 610 119,0
Current Liabilities 7,00 M 5,92 M 6,61 M 5,21 M 3,38 M